| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Risk Assessment
Record information and status
Record ID
101530
Status
Published
Date of creation
2011-01-20 14:04 UTC (german_bch@bvl.bund.de)
Date of last update
2020-07-16 14:42 UTC (german_bch@bvl.bund.de)
Date of publication
2020-07-21 07:05 UTC (nina.opitz@bmel.bund.de)

This document is also available in the following languages:
General Information
Country
  • Germany
Title of risk assessment
6786-01-0171 (adv. 42010.0171); Summary of the risk assessment of a deliberate release (field trial) of 4 lines of genetically modified oilseed rape (Brassica napus) transformed with plasmids pPSty5, pLH-BnSGT-GUS and pLH7000-SGT/SCT or combinations, issued by the German Competent Authority
Date of the risk assessment
2006-05-10
Competent National Authority(ies) responsible for the risk assessment
Federal Office of Consumer Protection and Food Safety
Mauerstrasse 39-42
Berlin
Germany, 10117
Phone:+49-(0)3018-445-6500
Fax:+49-(0)3018-445-6099
Email:german_bch@bvl.bund.de
Url:http://www.biosafety-bch.de (english language),BVL Homepage (English)
Risk assessment details
Living modified organism
Brassica napus modified for the synthesis of resveratrol
FINAB e. V. Changes in quality and/or metabolite content - Antioxidants, Flavonoids (e.g. anthocyanin) Resistance to antibiotics - Kanamycin Resistance to diseases and pests - Fungi Tolerance to abiotic stress
Brassica napus modified for reduced sinapine content (pLH-BnSGT-GUS)
FINAB e. V. Changes in quality and/or metabolite content - Protein and amino acids Resistance to herbicides - Glufosinate
Brassica napus modified for the synthesis of resveratrol and reduced sinapine content
FINAB e. V. Changes in quality and/or metabolite content - Antioxidants, Flavonoids (e.g. anthocyanin), Protein and amino acids Resistance to antibiotics - Kanamycin Resistance to diseases and pests - Fungi Resistance to herbicides - Glufosinate Tolerance to abiotic stress
Brassica napus modified for reduced sinapine content (pLH7000-SGT/SCT)
FINAB e. V. Changes in quality and/or metabolite content - Protein and amino acids Resistance to herbicides - Glufosinate Selectable marker genes and reporter genes
Scope of the risk assessment
Methodology and points to consider
Potential adverse effects identified in the risk assessment
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
Estimation of the overall risk
Adverse effects on human or animal health or on the environment are not expected.
Receiving environment(s) considered
1 field site in Germany, details see German LMO/GMO location register ( https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
LMO detection and identification methods proposed
construct specific PCR-based method

Records referencing this document (1)
IDDescription
1record(s) found
Country's Decision or any other Communication1 record